메뉴 건너뛰기




Volumn 49, Issue 5, 2015, Pages e41-e50

Adherence during antiviral treatment regimens for chronic Hepatitis C

Author keywords

compliance; dose; interferon; liver; psychological

Indexed keywords

ANTIVIRUS AGENT; PEGINTERFERON; RIBAVIRIN; ALPHA INTERFERON; MACROGOL DERIVATIVE;

EID: 84928590389     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000151     Document Type: Article
Times cited : (29)

References (26)
  • 1
    • 18244393776 scopus 로고    scopus 로고
    • Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin
    • McHutchison JG, Poynard T, Esteban-Mur R, et al. Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin. Hepatology. 2002;35: 688-693.
    • (2002) Hepatology. , vol.35 , pp. 688-693
    • McHutchison, J.G.1    Poynard, T.2    Esteban-Mur, R.3
  • 2
    • 84879755957 scopus 로고    scopus 로고
    • Adherence to PEG/ ribavirin treatment for chronic hepatitis C: Prevalence, patterns, and predictors of missed doses and nonpersistence
    • Evon DM, Esserman D, Bonner JE, et al. Adherence to PEG/ ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence. J Viral Hepat. 2013;20:536-549.
    • (2013) J Viral Hepat. , vol.20 , pp. 536-549
    • Evon, D.M.1    Esserman, D.2    Bonner, J.E.3
  • 3
    • 33845319863 scopus 로고    scopus 로고
    • New findings about patient adherence to prescribed drug dosing regimens: An introduction to pharmionics
    • Urquhart J, Vrijens B. New findings about patient adherence to prescribed drug dosing regimens: an introduction to pharmionics. Euro J Hosp Pharmacy Science. 2005;11: 103-106.
    • (2005) Euro J Hosp Pharmacy Science. , vol.11 , pp. 103-106
    • Urquhart, J.1    Vrijens, B.2
  • 4
    • 38549098101 scopus 로고    scopus 로고
    • Medication compliance and persistence: Terminology and definitions
    • Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11:44-47.
    • (2008) Value Health. , vol.11 , pp. 44-47
    • Cramer, J.A.1    Roy, A.2    Burrell, A.3
  • 5
    • 80052955087 scopus 로고    scopus 로고
    • Relationship between adherence to hepatitis C virus therapy and virologic outcomes: A cohort study
    • Lo RV III, Teal V, Localio AR, et al. Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study. Ann Intern Med. 2011;155: 353-360.
    • (2011) Ann Intern Med. , vol.155 , pp. 353-360
    • Lo, R.V.1    Teal, V.2    Localio, A.R.3
  • 6
    • 77954746102 scopus 로고    scopus 로고
    • Enhanced adherence to HCV therapy with higher dose ribavirin formulation: Final analyses from the ADHERE registry
    • Alam I, Stainbrook T, Cecil B, et al. Enhanced adherence to HCV therapy with higher dose ribavirin formulation: final analyses from the ADHERE registry. Aliment Pharmacol Ther. 2010;32:535-542.
    • (2010) Aliment Pharmacol Ther. , vol.32 , pp. 535-542
    • Alam, I.1    Stainbrook, T.2    Cecil, B.3
  • 7
    • 67449086883 scopus 로고    scopus 로고
    • Review article: Adherence to medication for chronic hepatitis C-building on the model of human immunodeficiency virus antiretroviral adherence research
    • Weiss JJ, Brau N, Stivala A, et al. Review article: adherence to medication for chronic hepatitis C-building on the model of human immunodeficiency virus antiretroviral adherence research. Aliment Pharmacol Ther. 2009;30:14-27.
    • (2009) Aliment Pharmacol Ther. , vol.30 , pp. 14-27
    • Weiss, J.J.1    Brau, N.2    Stivala, A.3
  • 8
    • 84855935309 scopus 로고    scopus 로고
    • The critical role of medication adherence in the success of boceprevir and telaprevir in clinical practice
    • Weiss JJ, Alcorn MC, Rabkin JG, et al. The critical role of medication adherence in the success of boceprevir and telaprevir in clinical practice. J Hepatol. 2012;56:503-504.
    • (2012) J Hepatol. , vol.56 , pp. 503-504
    • Weiss, J.J.1    Alcorn, M.C.2    Rabkin, J.G.3
  • 9
    • 36749081636 scopus 로고    scopus 로고
    • Views of hepatitis C virus patients delayed from treatment for psychiatric reasons
    • Rowan PJ, Dunn NJ, El-Serag HB, et al. Views of hepatitis C virus patients delayed from treatment for psychiatric reasons. J Viral Hepat. 2007;14:883-889.
    • (2007) J Viral Hepat. , vol.14 , pp. 883-889
    • Rowan, P.J.1    Dunn, N.J.2    El-Serag, H.B.3
  • 10
    • 68049097136 scopus 로고    scopus 로고
    • Lay management of chronic disease: A qualitative study of living with hepatitis C infection
    • Stoller EP, Webster NJ, Blixen CE, et al. Lay management of chronic disease: a qualitative study of living with hepatitis C infection. Am J Health Behav. 2009;33:376-390.
    • (2009) Am J Health Behav. , vol.33 , pp. 376-390
    • Stoller, E.P.1    Webster, N.J.2    Blixen, C.E.3
  • 11
    • 68149132783 scopus 로고    scopus 로고
    • Living with hepatitis C and treatment: The personal experiences of patients
    • Sgorbini M, O'Brien L, Jackson D. Living with hepatitis C and treatment: the personal experiences of patients. J Clin Nurs. 2009;18:2282-2291.
    • (2009) J Clin Nurs. , vol.18 , pp. 2282-2291
    • Sgorbini, M.1    O'brien, L.2    Jackson, D.3
  • 12
    • 78649243992 scopus 로고    scopus 로고
    • Uptake and delivery of hepatitis C treatment in opiate substitution treatment: Perceptions of clients and health professionals
    • Treloar C, Newland J, Rance J, et al. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals. J Viral Hepat. 2010;17:839-844.
    • (2010) J Viral Hepat. , vol.17 , pp. 839-844
    • Treloar, C.1    Newland, J.2    Rance, J.3
  • 13
    • 33845354318 scopus 로고    scopus 로고
    • How qualitative methods contribute to understanding combination antiretroviral therapy adherence
    • S54-68
    • Sankar A, Golin C, Simoni JM, et al. How qualitative methods contribute to understanding combination antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2006;43(suppl 1:S54-68):S54-S68.
    • (2006) J Acquir Immune Defic Syndr. , vol.43 , pp. S54-S68
    • Sankar, A.1    Golin, C.2    Simoni, J.M.3
  • 15
    • 33845286853 scopus 로고    scopus 로고
    • Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and facilitators
    • Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3:e438.
    • (2006) PLoS Med. , vol.3 , pp. e438
    • Mills, E.J.1    Nachega, J.B.2    Bangsberg, D.R.3
  • 16
    • 33746670549 scopus 로고    scopus 로고
    • An informationmotivation-behavioral skills model of adherence to antiretroviral therapy
    • Fisher JD, Fisher WA, Amico KR, et al. An informationmotivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25:462-473.
    • (2006) Health Psychol. , vol.25 , pp. 462-473
    • Fisher, J.D.1    Fisher, W.A.2    Amico, K.R.3
  • 17
    • 0037707373 scopus 로고    scopus 로고
    • Patient nonadherence to medication in inflammatory bowel disease
    • Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003;98:1535-1544.
    • (2003) Am J Gastroenterol. , vol.98 , pp. 1535-1544
    • Sewitch, M.J.1    Abrahamowicz, M.2    Barkun, A.3
  • 18
    • 33744825764 scopus 로고    scopus 로고
    • Patients' experiences related to anti-viral treatment for hepatitis C
    • Fraenkel L, McGraw S, Wongcharatrawee S, et al. Patients' experiences related to anti-viral treatment for hepatitis C. Patient Educ Couns. 2006;62:148-155.
    • (2006) Patient Educ Couns. , vol.62 , pp. 148-155
    • Fraenkel, L.1    McGraw, S.2    Wongcharatrawee, S.3
  • 19
    • 18844416899 scopus 로고    scopus 로고
    • Preferences for medical collaboration: Patient-physician congruence and patient outcomes
    • Jahng KH, Martin LR, Golin CE, et al. Preferences for medical collaboration: patient-physician congruence and patient outcomes. Patient Educ Couns. 2005;57:308-314.
    • (2005) Patient Educ Couns. , vol.57 , pp. 308-314
    • Jahng, K.H.1    Martin, L.R.2    Golin, C.E.3
  • 20
    • 84860243899 scopus 로고    scopus 로고
    • Help-seeking and coping with the psychosocial burden of chronic hepatitis C: A qualitative study of patient, hepatologist, and counsellor perspectives
    • Stewart BJ, Mikocka-Walus AA, Harley H, et al. Help-seeking and coping with the psychosocial burden of chronic hepatitis C: a qualitative study of patient, hepatologist, and counsellor perspectives. Int J Nurs Stud. 2012;49:560-569.
    • (2012) Int J Nurs Stud. , vol.49 , pp. 560-569
    • Stewart, B.J.1    Mikocka-Walus, A.A.2    Harley, H.3
  • 21
    • 84862231954 scopus 로고    scopus 로고
    • Understanding the behavioral determinants of retention in HIV care: A qualitative evaluation of a situated information, motivation, behavioral skills model of care initiation and maintenance
    • Smith LR, Fisher JD, Cunningham CO, et al. Understanding the behavioral determinants of retention in HIV care: a qualitative evaluation of a situated information, motivation, behavioral skills model of care initiation and maintenance. AIDS Patient Care STDS. 2012;26:344-355.
    • (2012) AIDS Patient Care STDS. , vol.26 , pp. 344-355
    • Smith, L.R.1    Fisher, J.D.2    Cunningham, C.O.3
  • 22
    • 0034536782 scopus 로고    scopus 로고
    • Taking antiretroviral therapy for HIV infection: Learning from patients' stories
    • Laws MB, Wilson IB, Bowser DM, et al. Taking antiretroviral therapy for HIV infection: learning from patients' stories. J Gen Intern Med. 2000;15:848-858.
    • (2000) J Gen Intern Med. , vol.15 , pp. 848-858
    • Laws, M.B.1    Wilson, I.B.2    Bowser, D.M.3
  • 23
    • 33847144019 scopus 로고    scopus 로고
    • Repeated measures analyses of dose timing of antiretroviral medication and its relationship to HIV virologic outcomes
    • Liu H, Miller LG, Golin CE, et al. Repeated measures analyses of dose timing of antiretroviral medication and its relationship to HIV virologic outcomes. Stat Med. 2007;26:991-1007.
    • (2007) Stat Med. , vol.26 , pp. 991-1007
    • Liu, H.1    Miller, L.G.2    Golin, C.E.3
  • 24
    • 80052035379 scopus 로고    scopus 로고
    • Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo
    • Hiraga N, Imamura M, Abe H, et al. Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo. Hepatology. 2011;54:781-788.
    • (2011) Hepatology. , vol.54 , pp. 781-788
    • Hiraga, N.1    Imamura, M.2    Abe, H.3
  • 25
    • 78649451033 scopus 로고    scopus 로고
    • Improving compliance to meal-replacement food regimens Forming implementation intentions (conscious IF-THEN plans) increases compliance
    • Zandstra EH, den HW, van der MN, et al. Improving compliance to meal-replacement food regimens. Forming implementation intentions (conscious IF-THEN plans) increases compliance. Appetite. 2010;55:666-670.
    • (2010) Appetite. , vol.55 , pp. 666-670
    • Zandstra, E.H.1    Den, H.W.2    Van Der, M.N.3
  • 26
    • 84863315588 scopus 로고    scopus 로고
    • The application of the yerkes-dodson law in a childhood weight management program: Examining weight dissatisfaction
    • Johnston CA, Moreno JP, Regas K, et al. The application of the yerkes-dodson law in a childhood weight management program: examining weight dissatisfaction. J Pediatr Psychol. 2012;37:674-679.
    • (2012) J Pediatr Psychol. , vol.37 , pp. 674-679
    • Johnston, C.A.1    Moreno, J.P.2    Regas, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.